E11.3552 Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

Name of the Condition

• Common Name: Type 2 Diabetes with Stable Proliferative Diabetic Retinopathy, Left Eye
• Medical Term: Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye

Summary

This condition is a severe complication of type 2 diabetes characterized by the growth of abnormal new blood vessels in the retina of the left eye, with no active progression or worsening of retinal changes. It arises from prolonged high blood sugar levels damaging retinal blood vessels, potentially leading to vision impairment or blindness if untreated. The "stable" designation indicates that the proliferative changes are not actively advancing, though ongoing monitoring is essential.

Causes

High blood sugar levels over time damage the small blood vessels in the retina, triggering the growth of fragile, abnormal blood vessels. This process is driven by diabetes-related vascular changes and metabolic imbalances, which disrupt normal retinal function and structure. In the stable phase, the abnormal vessels are present but not actively proliferating or causing new complications.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and high cholesterol.
• Smoking and obesity.
• Family history of diabetic eye disease.

Symptoms

• Often asymptomatic in early stages.
• Blurred or distorted vision.
• Floaters or dark spots in the visual field.
• Sudden vision loss in severe cases.

Diagnosis

Diagnosis requires a comprehensive dilated eye exam by an ophthalmologist, often supplemented by fundus photography, fluorescein angiography, or optical coherence tomography to assess retinal changes and confirm the stable proliferative stage.

Treatment Options

• Laser photocoagulation to reduce abnormal blood vessel growth.
• Intravitreal anti-VEGF injections to inhibit vascular proliferation.
• Regular monitoring to detect progression or complications.
• Blood sugar and blood pressure control to slow disease advancement.

Prognosis and Follow-Up

With proper management, vision loss can be prevented or minimized. Follow-up typically includes regular eye exams every 3–6 months to monitor for changes. Adherence to diabetes management and lifestyle modifications improves long-term outcomes.

Complications

• Vision impairment or blindness if untreated.
• Retinal detachment.
• Vitreous hemorrhage.
• Glaucoma.

Lifestyle & Prevention

• Maintain tight glycemic control through diet, exercise, and medication.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Schedule annual dilated eye exams for early detection.

When to Seek Professional Help

Seek immediate care for sudden vision changes, increased floaters, or eye pain, as these may indicate progression or complications requiring urgent intervention.

Tips for Medical Coders

Document the specific eye (left) and the stable nature of the proliferative retinopathy. Ensure clinical notes support the absence of active progression to justify the "stable" designation. Verify that the code aligns with the documented eye involvement and retinopathy status.